Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma

Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma

In this study, we developed a novel poly (lactic-co-glycolic acid)-dextran (PLD)-based nanodelivery system to enhance the anticancer potential of cisplatin (CDDP) in osteosarcoma cells. A nanosized CDDP-loaded PLGA-DX nanoparticle (PLD/CDDP) controlled the release rate of CDDP up to 48 h. In vitro c...

Full description

Bibliographic Details
Main Authors: Liu, Ping, Sun, Liang, Zhou, Dong-sheng, Zhang, Peng, Wang, Yong-hui, Li, Dong, Li, Qing-hu, Feng, Rong-jie
Format: Online
Language:English
Published: Nature Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664968/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664968/

Similar Items